BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17.01.2008

Intramammary Dosage Forms; Cephapirin Sodium

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of supplemental new animal drug applications (NADAs) filed by Fort Dodge Animal Health, Division of Wyeth. The supplemental NADAs provide for revisions to the labeling of two cephapirin sodium products administered by intramammary infusion to lactating cows for the treatment of mastitis.

Source: Federal Register — Food and Drug AdministrationOpen original release →